It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
To investigate the predictive value of the central arterial waveform for intradialytic blood pressure (BP) change, a total of 152 hemodialysis patients (mean age 68 years) on a thrice-weekly hemodialysis schedule were enrolled, and at both the first and second session of the week, BP and central arterial waveform were measured every 30 min during hemodialysis. In both sessions, a 1-standard deviation increase in baseline subendocardial viability ratio (SEVR), an index of subendocardial perfusion, as well as in baseline systolic BP (SBP) was an independent predictor of maximum SBP decrease ≥ 30 mmHg during hemodialysis. When divided into four groups based on the respective median level of SEVR in the SBP ≥ median and SBP < median groups, intradialytic SBP change was different among the subgroups. Multiple logistic regression analysis revealed that, compared with the SBP < median; low SEVR group, the SBP < median; high SEVR group had lower risk, and the SBP ≥ median; low SEVR group had higher risk of SBP decrease ≥ 30 mmHg, but the risk did not differ from that in the SBP ≥ median; high SEVR group. Predialysis subendocardial perfusion evaluated by SEVR was associated with the maximum intradialytic BP decrease, and evaluation of the central arterial waveform could be used as complementary screening for intradialytic BP change.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Kansai Medical University Kori Hospital, Department of Internal Medicine, Neyagawa, Japan (GRID:grid.410783.9) (ISNI:0000 0001 2172 5041); Dokkyo Medical University, Department of Nephrology and Hypertension, Mibu, Japan (GRID:grid.255137.7) (ISNI:0000 0001 0702 8004)
2 Mooka Hospital, Division of Internal Medicine, Moka, Japan (GRID:grid.255137.7)
3 Clinic of Utsunomiya Jinn-naika-hifuka, Division of Internal Medicine, Utsunomiya, Japan (GRID:grid.255137.7)
4 Ishikiriseiki Hospital, Department of Cardiovascular Medicine, Higashiosaka, Japan (GRID:grid.414831.b)
5 Dokkyo Medical University, Department of Nephrology and Hypertension, Mibu, Japan (GRID:grid.255137.7) (ISNI:0000 0001 0702 8004)